Just over 4,200 people could be set to benefit after Sparsentan (also known as Filspari and made by Vifor Pharma) was recommended in final draft guidance as an option for treating primary ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

No needles, no downtime, no transplants. TED by Alma is the ultrasound-powered, noninvasive hair restoration treatment ...

Pelago provides personalized treatment for Blue Cross members experiencing opioid or alcohol dependency, offering three ...

Clear signs of immune activation: ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune ...

Realizing their options for medically assisted death are so far limited in New York, a Catskills couple decided to seek it in Oregon.

NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

The sweeping bill is designed to address industry practices that critics say limit patients’ access to care, including mental ...

Fungal pathogens like Aspergillus species are known for their ability to infect humans, livestock, and crops, causing severe ...

The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.

UCLA and USC surgeons performed the world’s first in-human bladder transplant this month, and now, thanks to them, the patient can produce urine for the first time in seven years. Officials ...